MACROLIDES WITH VEGF TRANSCRIPTION SUPPRESSION ACTIVITY

The present invention provides a novel bioactive substance having an antitumor activity and a process for producing it, and a medical use thereof. Namely, it provides a 12-membered ring macrolide compound represented by the following formula obtained from the incubation solution of Streptomyces sp....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAMAMOTO, SATOSHI, TSUCHIDA, TOSHIO, SAKAI, TAKASHI, NAGAI, MITSUO, OKAMOTO, KIYOSHI, FUJITA, MASANORI, KOMEDA, KEISUKE, NIIJIMA, JUN, YAMADA, TOMONARI, OKUDA, AKIFUMI, YAMORI, TAKAO, YOSHIDA, MASASHI, KOTAKE, YOSHIHIKO, MATSUFUJI, MOTOKO, KISHI, KUMIKO, MIZUI, YOSHIHARU, NAKASHIMA, TAKASHI, KAWAMURA, NAOTO, DOBASHI, KAZUYUKI, UENAKA, TOSHIMITSU, ASAI, NAOKI, SAMESHIMA, TOMOHIRO, NORIHISA, KOJI, IWATA, MASAO, TAKEDA, SUSUMU
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a novel bioactive substance having an antitumor activity and a process for producing it, and a medical use thereof. Namely, it provides a 12-membered ring macrolide compound represented by the following formula obtained from the incubation solution of Streptomyces sp. Mer. 11107 or a variant thereof, a pharmacologically acceptable salt thereof or a hydrate of them, and a process for producing it.